Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors
The footprint of human endogenous retroviruses (HERV), specifically HERV-K, has been found in malignancies, such as melanoma, teratocarcinoma, osteosarcoma, breast cancer, lymphoma, and ovary and prostate cancers. HERV-K is characterized as the most biologically active HERV due to possession of open...
Egile Nagusiak: | Sepideh Hosseiniporgham, Leonardo Antonio Sechi |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
MDPI AG
2023-03-01
|
Saila: | Vaccines |
Gaiak: | |
Sarrera elektronikoa: | https://www.mdpi.com/2076-393X/11/4/751 |
Antzeko izenburuak
-
HERV-K and HERV-H Env Proteins Induce a Humoral Response in Prostate Cancer Patients
nork: Maria Antonietta Manca, et al.
Argitaratua: (2022-01-01) -
HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer
nork: Simin D. Rezaei, et al.
Argitaratua: (2021-03-01) -
HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA
nork: Laurie R. Gray, et al.
Argitaratua: (2019-12-01) -
HERV-K(HML7) Integrations in the Human Genome: Comprehensive Characterization and Comparative Analysis in Non-Human Primates
nork: Nicole Grandi, et al.
Argitaratua: (2021-05-01) -
Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival
nork: Maria Giebler, et al.
Argitaratua: (2018-02-01)